We are live on ! Find out more
IART icon

Integra LifeSciences

223 hedge funds and large institutions have $2.96B invested in Integra LifeSciences in 2016 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 95 increasing their positions, 61 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

477% more call options, than puts

Call options by funds: $12M | Put options by funds: $2.08M

185.69% more ownership

Funds ownership: 0%185.69% (+186%)

56% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 61

8% more capital invested

Capital invested by funds: $2.75B → $2.96B (+$211M)

5% less funds holding

Funds holding: 234223 (-11)

22% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 41

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
223
Holders Change
-11
Holders Change %
-4.7%
% of All Funds
5.58%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
32
Increased
95
Reduced
61
Closed
41
Calls
$12M
Puts
$2.08M
Net Calls
+$9.9M
Net Calls Change
+$1.89M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$454M +$9.08M +223,464 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$224M +$7.24M +178,214 +4%
BFA
3
BlackRock Fund Advisors
California
$208M +$21.3M +523,814 +12%
Wells Fargo
4
Wells Fargo
California
$179M +$21.3M +524,634 +14%
CIP
5
Champlain Investment Partners
Vermont
$169M +$27.9M +686,032 +21%
Capital Research Global Investors
6
Capital Research Global Investors
California
$79.9M +$1.41M +34,800 +2%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$73.3M -$2.94M -72,212 -4%
Invesco
8
Invesco
Georgia
$68.6M +$50.1M +1,233,426 +336%
BIT
9
BlackRock Institutional Trust
California
$67.2M +$3.65M +89,892 +6%
Victory Capital Management
10
Victory Capital Management
Texas
$61.7M -$4.27M -105,010 -7%
State Street
11
State Street
Massachusetts
$59.3M +$3.3M +81,090 +6%
ClearBridge Investments
12
ClearBridge Investments
New York
$54.7M -$38.9K -956 -0.1%
Goldman Sachs
13
Goldman Sachs
New York
$52M +$3.91M +96,188 +9%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$48.5M -$1.6M -39,260 -3%
Fisher Asset Management
15
Fisher Asset Management
Washington
$44.7M -$413K -10,150 -1%
JHIU
16
Janus Henderson Investors US
Colorado
$43.9M +$41.6M +1,024,340 New
EAM
17
Eagle Asset Management
Florida
$42.7M +$35.7M +877,610 +741%
Northern Trust
18
Northern Trust
Illinois
$37.6M +$3.75M +92,326 +12%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$37.1M -$9.94M -244,486 -22%
Massachusetts Financial Services
20
Massachusetts Financial Services
Massachusetts
$36.1M +$3.89M +95,726 +13%
HRCM
21
Hood River Capital Management
Florida
$32.8M +$5M +122,914 +19%
Boston Partners
22
Boston Partners
Massachusetts
$32.5M -$2.69M -66,152 -8%
Norges Bank
23
Norges Bank
Norway
$31.8M -$11.5M -283,212 -28%
Westfield Capital Management
24
Westfield Capital Management
Massachusetts
$29.9M -$5.79M -142,428 -17%
ACM
25
Atlanta Capital Management
Georgia
$28.9M +$2.89M +71,094 +12%

IART Hedge Fund Activity: Q4 2016 in Review

223 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2016, worth a combined $2.96B — up 7.7% from $2.75B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of IART and 32 opened new positions — a net loss of 9 holders — while 61 trimmed existing stakes and 95 added.

The largest buyer was Invesco, adding an estimated $50.1M. The largest seller was Westwood Holdings Group, cutting an estimated $36.6M.

  • 223 institutional investors held Integra LifeSciences (IART) as of Q4 2016, down from 234 in Q3 2016.
  • Funds reported $2.96B of Integra LifeSciences stock for Q4 2016, up 7.7% quarter-over-quarter.
  • 32 funds opened new Integra LifeSciences positions in Q4 2016 and 41 closed out, a net change of -9 holders.
  • The largest Integra LifeSciences buyer in Q4 2016 was Invesco, an estimated $50.1M added.
  • The largest Integra LifeSciences seller in Q4 2016 was Westwood Holdings Group, an estimated $36.6M sold.

Based on aggregated 13F filings for Q4 2016.